
2026年4月,美国Capintec公司全球总经理、亚太区负责人一行莅临北京,与beat365手机中文官方网站技术团队举行深度会晤。双方围绕精准医疗与辐射安全领域的技术创新、产品升级、市场拓展及本土化服务展开深入交流,进一步夯实长期战略合作,携手推动行业高质量发展。
Capintec作为全球精准医疗与辐射测量领域企业,深耕行业六十余年,凭借放射性检测、辐射监测技术及高品质仪器设备树立*;北京东方圆通作为Capintec中国区授权代理商,深耕本土市场多年,搭建技术支持、产品销售、售后维保全链条服务体系,是行业内值得信赖的合作伙伴。
会晤期间,双方回顾合作成果,高度认可CRC系列放射性检测仪器、伽马分析仪器等核心产品在国内医院、科研机构的应用口碑。东方圆通分享国内市场需求与服务升级规划,Capintec介绍全球技术研发方向、新品计划及亚太市场布局,双方就技术协同、产品供给、售后完善达成重要共识。
未来,双方将聚焦精准诊疗、辐射安全防护领域,加速新品落地,强化技术培训与售后响应,依托资源优势开拓新场景,为医疗机构、科研单位提供更专业高效的解决方案。此次会晤为双方合作树立重要里程碑,也为行业发展注入新动能。东方圆通将持续携手Capintec,以创新驱动、优质服务深耕本土,助力精准医疗与辐射安全行业迈向更高水平。
Deepening Strategic Cooperation to Explore New Opportunities in Nuclear Medicine | Capintec Global Executives Visit Beijing Oriental Yuantong to Discuss High‑Quality Industry Development.
In April 2026, the Global General Manager and Asia‑Pacific Regional Director of Capintec Inc. (USA) visited Beijing and held an in‑depth meeting with the technical team of Beijing Oriental Yuantong Technology Development Co., Ltd. The two sides conducted extensive exchanges on technological innovation, product upgrading, market expansion, and localized services in precision medicine and radiation safety, further consolidating their long‑term strategic partnership and jointly promoting high‑quality development of the industry.
As a leading enterprise in precision medicine and radiation measurement worldwide, Capintec has over 60 years of industry experience and has established an exemplary role in the sector with cutting‑edge radioactivity detection, radiation monitoring technologies, and high‑quality instruments. As the official authorized agent of Capintec in China, Beijing Oriental Yuantong has deeply rooted in the domestic market for many years, building a full‑chain service system covering technical support, product sales, and after‑sales maintenance, making it a reliable partner in the industry.
During the meeting, both sides reviewed the achievements of previous cooperation and highly recognized the reputation of core products such as the CRC series radioactivity detectors and gamma analyzers in domestic hospitals and research institutions. Oriental Yuantong shared domestic market demands and service upgrade plans, while Capintec introduced global R&D directions, new product plans, and Asia‑Pacific market layout. Important consensus was reached on technological collaboration, product supply, and after‑sales improvement.
In the future, both parties will focus on precision diagnosis and treatment and radiation safety, accelerate the launch of new products in China, strengthen technical training and after‑sales response, and explore new application scenarios based on complementary advantages, providing more professional and efficient solutions for medical institutions and research units. This meeting marks an important milestone in their cooperation and injects new momentum into industry development. Oriental Yuantong will continue to partner with Capintec, driven by innovation and supported by quality services, to deeply develop the local market and help the precision medicine and radiation safety industry reach a higher level.